Latest Regulatory News

Port of Tauranga is facing three appeals and two judicial review applications against approval for its Stella Passage expansion. The port plans to defend the consent and seek a single expedited High Court hearing, but the filing does not quantify possible delays or costs.

SkyCity Entertainment Group has secured the right to apply for two New Zealand online casino licences, committing NZ$30 million in licence fees before GST. The company still needs to complete the application process ahead of next year’s planned market opening.

Berkeley Energia says it is unaware of any undisclosed information that could explain a sharp rise in its shares, after ASX sought answers as the stock approached $0.95. The company pointed only to Spain’s decision to bring forward its general election.

Anatara Lifesciences will manufacture an approximately 10,000-capsule demonstration batch of its AOC anti-obesity compound after deciding further pre-clinical work and an immediate clinical trial are not required. The company ended September with $551,000 in cash, helped by a $318,402 R&D tax rebate.

PointsBet expects first-half FY27 revenue of approximately $113 million, down 16% from the prior corresponding period, with normalised EBITDA falling to a loss of $6 million to $8 million. The company attributed the setback to stricter Australian compliance measures and adverse betting results, particularly in AFL.

The US FDA has supported six of seven elements NeuroScientific Biopharmaceuticals put forward for its planned StemSmart Phase 2 Crohn’s disease trial. The remaining issue is a manufacturing control for viral contamination, while trial commencement remains targeted for the end of 2026 and subject to further requirements.

Kinetiko Energy is preparing to submit a permit that could allow limited gas sales from its Brakfontein project in early 2027, while engineering, procurement and drilling plans advance in parallel. The company has also shortlisted three candidates for its next chief executive.

Maronan Metals has secured firm commitments for a $20 million placement to expand drilling and bring forward engineering, permitting and metallurgical work at its Queensland project. The raise is conditional on shareholder approval, with Kinterra Capital set to lift its interest to 22.99%.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.

WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.

EDU Holdings has lifted total enrolments 26% to a record 7,489, with Higher Education up 45% and now accounting for 88% of the group. The result also exposes a sharper divide: domestic and postgraduate demand is strengthening, while international VET enrolments continue to contract.